A research team at Mass General Brigham has released new evidence directly comparing how well tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) protect the heart. According to the analysis, both medications lowered the chances of…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply